3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
22
Lymphoma
14
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Breast Neoplasms
11
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Multiple Myeloma
9
Melanoma
9
Lymphoma, Follicular
9
Neuroblastoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Ovarian Neoplasms
7
Congenital Abnormalities
7
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Chronic-Phase
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Lenalidomide
8
Dexamethasone
6
Calcium Dobesilate
6
Melphalan
3
elotuzumab
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
daratumumab
2
auricularum
2
Peripheral Blood Stem Cell Transplantation
2
Bortezomib
2
pomalidomide
1
piperine
1
pembrolizumab
1
ixazomib
1
ibrutinib
1
Watchful Waiting
1
Urination
1
Transplantation, Autologous
1
Stem Cell Transplantation
1
Receptors, Interleukin-6
1
Observation
1
Nivolumab
1
Metformin
1
Interleukin 1 Receptor Antagonist Protein
1
In Situ Hybridization, Fluorescence
1
IPH-2101
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Smoldering Multiple Myeloma
×
sargramostim
×
Clear all
No trials found.